InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
33%
T+90 mean return
-5.9%
Across 18 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Willoughby Scott B., SVP, Conseiller Général et Secrétaire. Officer active across 1 company, notably Sangamo Therapeutics, INC. Cumulatively, 23 disclosures have been logged. History available since 13 August 2021. The latest transaction was disclosed on 22 April 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations23 total
31,866 shares@ US$0.77639.9% of flowCommon StockSEC:0001415889-25-011287:0
1,434 shares@ US$1.000.6% of flowCommon StockSEC:0001415889-25-005706:0
129,549 shares@ US$1.1565.3% of flowCommon StockSEC:0001415889-25-002021:0
1,430 shares@ US$1.881.2% of flowCommon StockSEC:0001415889-24-027705:0
1,430 shares@ US$0.860.5% of flowCommon StockSEC:0001415889-24-022312:0
892 shares@ US$0.97510.4% of flowCommon StockSEC:0001415889-24-021365:0
1,400 shares@ US$0.600.4% of flowCommon StockSEC:0001415889-24-014796:0
4,379 shares@ US$1.132.1% of flowCommon StockSEC:0001415889-24-005550:0
712,500 shares0Common StockSEC:0001415889-24-001757:0
1,329 shares@ US$0.38210.2% of flowCommon StockSEC:0001209191-23-056791:0
1,329 shares@ US$0.770.4% of flowCommon StockSEC:0001209191-23-047577:0
864 shares@ US$1.080.4% of flowCommon StockSEC:0001209191-23-045879:0
1,328 shares@ US$1.330.8% of flowCommon StockSEC:0001209191-23-032914:0
3,977 shares@ US$1.652.7% of flowCommon StockSEC:0001209191-23-025721:0
42,750 shares0Common StockSEC:0001209191-23-016399:0
864 shares@ US$6.332.4% of flowCommon StockSEC:0001209191-22-046022:0
140 shares@ US$4.150.0004% mcap2.0% of flowCommon StockSEC:0001209191-22-026801:0
3,976 shares@ US$4.700.012% mcap61.6% of flowCommon StockSEC:0001209191-22-025671:0
1,566 shares@ US$5.900.0056% mcap29.4% of flowCommon StockSEC:0001209191-22-014179:0
140 shares@ US$8.120.0007% mcap3.5% of flowCommon StockSEC:0001209191-21-062653:0
140 shares@ US$8.120.4% of flowCommon StockSEC:0001209191-21-062653
7,500 shares0Common StockSEC:0001209191-21-051997
7,500 shares0Common StockSEC:0001209191-21-051997:0
23 of 23 declarations
About Willoughby Scott B.
Scott B. Willoughby is the Senior Vice President, General Counsel and Secretary of SANGAMO THERAPEUTICS, INC. In this role, he oversees the company's legal affairs and regulatory compliance. Scott brings valuable expertise in the legal field, contributing to SANGAMO's overall strategy.
